Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relation between debrisoquine oxidation phenotype and morphological, biological, and pathological variables in a large population.

Clinical chemistry - 1 Mar 1991

Vincent-Viry M, Muller J, Fournier B, Galteau M M, Siest G

Abstract excerpt

Factors affecting biological variations in debrisoquine-oxidation polymorphism were investigated in a population of 3065 unrelated supposedly healthy Caucasian subjects, ages 35 to 50 years. This population, including 1526 men and 1539 women, was used to determine whether the debrisoquine-oxidation phenotype can be related with environmental factors such as alcohol intake, smoking habits or medication; with...

Topics

Administration, Oral
Adult
Alcohol Drinking
Debrisoquin
Female
Humans
Hydroxylation
Male
Middle Aged
Phenotype
Polymorphism, Genetic
Sex Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Smoking

Source

Identifiers

PMID: 2004438

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-2004438-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relation between debrisoquine oxidation phenotype and morphological, biological, and pathological variables in a large population.PMID 2004438Read ↗

Polymorphic debrisoquin metabolism in a Turkish population.Semantic proximity Read ↗

Determination of debrisoquine oxidation phenotype in healthy volunteers during phase I trials.Semantic proximity Read ↗

Debrisoquine metabolism and lung cancer risk.Semantic proximity Read ↗

Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes.Semantic proximity Read ↗

Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation CapacitySemantic proximity Read ↗

Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.Semantic proximity Read ↗

Lack of relationship between debrisoquine oxidation phenotype and the pharmacokinetics of quinine.Semantic proximity Read ↗

Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes.Semantic proximity Read ↗

Debrisoquine hydroxylation phenotyping in geriatric psychopharmacology.Semantic proximity Read ↗

3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.Semantic proximity Read ↗

Metabolism of almitrine in extensive and poor metabolisers of debrisoquine/sparteine.Semantic proximity Read ↗

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics of chlorpropamide.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.